ADVM vs CVM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ADVM Captures Institutional Edge (2โ2 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adverum Biotechnologies, Inc. Common Stock (ADVM) driven by superior Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation, Growth & Margin. Fundamentally, ADVM trades at N/M Forward P/E with 0.0% operating margin (-70.0% YoY revenue) versus CVM at 23.0x Forward P/E and 0.0% operating margin (-62.7% YoY). In options structure, ADVM sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro) against CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ADVM | CVM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $91.8M | $20.9M | Larger Scale | ADVM |
| Trailing P/E Ratio Valuation | N/M | 23.0x | Lower Multiple | CVM |
| Forward P/E Ratio Valuation | N/M | 23.0x | Lower Multiple | CVM |
| Revenue Growth (YoY) Growth | -70.0% | -62.7% | Higher Growth | CVM |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -417.8% | -252.5% | Higher ROE | CVM |
| 52-Week Range Position Momentum | 55% ($2โ$6) | 10% ($1โ$8) | Stronger Trend | ADVM |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 17% Vol | 0.65ฮฒ ยท 120% Vol | Lower Realized Risk | ADVM |
| Unified Institutional Score Composite Signal | 62.4 / 100 (BUY) | 56.6 / 100 (HOLD) | Higher Composite | ADVM |